FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898613997> ?p ?o ?g. }

• W2898613997 endingPage "S755" @default.
• W2898613997 startingPage "S754" @default.
• W2898613997 abstract "Although Therapies for mesothelioma have been developed, their efficacy remains limited. Newer therapies based on improved molecular understanding of mesothelioma are needed. We have previously found that proliferation of mesothelioma cell lines is suppressed by transfecting small interfering RNA (siRNA) of dishevelled-3 (Dvl-3), an intermediator of Wnt signaling. Furthermore, when analysis of various mesothelioma cell lines using two-dimensional gel electrophoresis assay was conducted, heat shock protein 70 (HSP70) expression was commonly suppressed after transfection of Dvl-3 siRNA. To clarify the effect of inhibiting HSP70 function in mesothelioma cell lines, a small molecular compound VER-155008, adenosine-derived inhibitor of HSP70, was treated to cells, and its effects were evaluated. VER-155008 is adopted in various researches including Alzheimer’s disease, infectious diseases and so on, and other reports showed that it inhibits the function of HSP70 without altering the expression of HSP70. Mesothelioma MSTO-211H (211H), NCI-H2452 (H2452) and NCI-H28 (H28) cell lines were cultured with VER-155008 for the following analyses. The expression of HSP70 was confirmed using Western blotting. Cell viability was estimated using Cell Counting Kit-8 at 24, 48 and 72 h after adding 0.5–40 μM VER-155008 while mesothelioma cell lines were cultured on 96-well plates at 500-1000 cells/well. Colony formation and cell cycle analysis was conducted, after mesothelioma cell lines were cultured with 1–20 μM VER-155008 on 35-mm dishes. Furthermore, to estimate the synergistic effect with other anticancer drugs on cell growth, mesothelioma cell lines were cultured with VER-155008 and 0.5-5 μM cisplatin or gefitinib HSP70 protein was expressed in mesothelioma cells: 211H, H2452 and H28. Its expression was not altered by VER-155008 in these cells. VER-155008 dose-dependently suppressed mesothelioma cell growth. The colony formation was significantly suppressed with VER-155008 at 20 μM. The proportion of cell counts in G1 phase significantly increased in 211H and H28 cells. Cisplatin or gefitinib did not show synergistic growth suppression after 48 h of treatment with VER-155008. These results suggest that VER-155008 have ability to suppress mesothelioma proliferation with G1 arrest through inhibition of HSP70 function. Furthermore, we will elucidate HSP70 function and its relationship with other mechanisms for proliferation and surviving including signal transduction and autophagy in mesothelioma." @default.
• W2898613997 created "2018-11-02" @default.
• W2898613997 creator A5007761788 @default.
• W2898613997 creator A5015983638 @default.
• W2898613997 creator A5022911422 @default.
• W2898613997 creator A5032710108 @default.
• W2898613997 creator A5033163209 @default.
• W2898613997 creator A5048975251 @default.
• W2898613997 creator A5052951502 @default.
• W2898613997 creator A5054091102 @default.
• W2898613997 creator A5057779938 @default.
• W2898613997 creator A5060570462 @default.
• W2898613997 creator A5066682743 @default.
• W2898613997 creator A5067999712 @default.
• W2898613997 creator A5081568747 @default.
• W2898613997 creator A5090421586 @default.
• W2898613997 date "2018-10-01" @default.
• W2898613997 modified "2023-09-27" @default.
• W2898613997 title "P2.06-31 Inhibition of Heat Shock Protein 70 Function Suppresses Proliferation in Mesothelioma Cells" @default.
• W2898613997 doi "https://doi.org/10.1016/j.jtho.2018.08.1286" @default.
• W2898613997 hasPublicationYear "2018" @default.
• W2898613997 type Work @default.
• W2898613997 sameAs 2898613997 @default.
• W2898613997 citedByCount "0" @default.
• W2898613997 crossrefType "journal-article" @default.
• W2898613997 hasAuthorship W2898613997A5007761788 @default.
• W2898613997 hasAuthorship W2898613997A5015983638 @default.
• W2898613997 hasAuthorship W2898613997A5022911422 @default.
• W2898613997 hasAuthorship W2898613997A5032710108 @default.
• W2898613997 hasAuthorship W2898613997A5033163209 @default.
• W2898613997 hasAuthorship W2898613997A5048975251 @default.
• W2898613997 hasAuthorship W2898613997A5052951502 @default.
• W2898613997 hasAuthorship W2898613997A5054091102 @default.
• W2898613997 hasAuthorship W2898613997A5057779938 @default.
• W2898613997 hasAuthorship W2898613997A5060570462 @default.
• W2898613997 hasAuthorship W2898613997A5066682743 @default.
• W2898613997 hasAuthorship W2898613997A5067999712 @default.
• W2898613997 hasAuthorship W2898613997A5081568747 @default.
• W2898613997 hasAuthorship W2898613997A5090421586 @default.
• W2898613997 hasBestOaLocation W28986139971 @default.
• W2898613997 hasConcept C104317684 @default.
• W2898613997 hasConcept C142724271 @default.
• W2898613997 hasConcept C1491633281 @default.
• W2898613997 hasConcept C153911025 @default.
• W2898613997 hasConcept C205260736 @default.
• W2898613997 hasConcept C22615655 @default.
• W2898613997 hasConcept C2777407522 @default.
• W2898613997 hasConcept C502942594 @default.
• W2898613997 hasConcept C54009773 @default.
• W2898613997 hasConcept C54355233 @default.
• W2898613997 hasConcept C55493867 @default.
• W2898613997 hasConcept C62112901 @default.
• W2898613997 hasConcept C68991219 @default.
• W2898613997 hasConcept C71924100 @default.
• W2898613997 hasConcept C81885089 @default.
• W2898613997 hasConcept C86803240 @default.
• W2898613997 hasConceptScore W2898613997C104317684 @default.
• W2898613997 hasConceptScore W2898613997C142724271 @default.
• W2898613997 hasConceptScore W2898613997C1491633281 @default.
• W2898613997 hasConceptScore W2898613997C153911025 @default.
• W2898613997 hasConceptScore W2898613997C205260736 @default.
• W2898613997 hasConceptScore W2898613997C22615655 @default.
• W2898613997 hasConceptScore W2898613997C2777407522 @default.
• W2898613997 hasConceptScore W2898613997C502942594 @default.
• W2898613997 hasConceptScore W2898613997C54009773 @default.
• W2898613997 hasConceptScore W2898613997C54355233 @default.
• W2898613997 hasConceptScore W2898613997C55493867 @default.
• W2898613997 hasConceptScore W2898613997C62112901 @default.
• W2898613997 hasConceptScore W2898613997C68991219 @default.
• W2898613997 hasConceptScore W2898613997C71924100 @default.
• W2898613997 hasConceptScore W2898613997C81885089 @default.
• W2898613997 hasConceptScore W2898613997C86803240 @default.
• W2898613997 hasIssue "10" @default.
• W2898613997 hasLocation W28986139971 @default.
• W2898613997 hasOpenAccess W2898613997 @default.
• W2898613997 hasPrimaryLocation W28986139971 @default.
• W2898613997 hasRelatedWork W2001686617 @default.
• W2898613997 hasRelatedWork W2057925004 @default.
• W2898613997 hasRelatedWork W2160379231 @default.
• W2898613997 hasRelatedWork W2351812146 @default.
• W2898613997 hasRelatedWork W2357994641 @default.
• W2898613997 hasRelatedWork W2358285435 @default.
• W2898613997 hasRelatedWork W2371441531 @default.
• W2898613997 hasRelatedWork W2379763872 @default.
• W2898613997 hasRelatedWork W2381439765 @default.
• W2898613997 hasRelatedWork W2410725769 @default.
• W2898613997 hasVolume "13" @default.
• W2898613997 isParatext "false" @default.
• W2898613997 isRetracted "false" @default.
• W2898613997 magId "2898613997" @default.
• W2898613997 workType "article" @default.